Results 41 to 50 of about 4,157,974 (295)

LIVER RESECTION FOR METASTASES FROM COLORECTAL CANCER [PDF]

open access: yesMedical Journal Armed Forces India, 1999
Five percent of patients with liver secondaries from colorectal carcinoma are potentially resectable and several studies have demonstrated significantly improved survival following resection. Two hundred and ten patients operated for colorectal carcinoma were followed up.
H G, Mukhopadhyay   +6 more
openaire   +2 more sources

Tumor-suppressive role of Smad ubiquitination regulatory factor 2 in patients with colorectal cancer

open access: yesScientific Reports, 2022
Smad ubiquitination regulatory factor 2 (Smurf2) plays various roles in cancer progression. However, the correlation between Smurf2 and clinical outcomes has not been determined in patients diagnosed with colorectal cancer and colorectal liver metastases.
Nami Sato   +9 more
doaj   +1 more source

Hepatic resection for primary and secondary liver malignancies

open access: yesInnovative Surgical Sciences, 2017
Liver surgery has become the standard treatment of primary liver cancer and liver metastases from colorectal cancer. Also, patients with non-colorectal liver metastases are increasingly offered surgery due to the low morbidity and excellent long-term ...
Heinrich Stefan, Lang Hauke
doaj   +1 more source

Radiofrequency Ablation for Colorectal Cancer Liver Metastases: Outcomes and Prognostic Factors Associated with Survival

open access: yes, 2023
Background: To determine the long-term outcomes of radiofrequency ablation with respect to overall survival, disease-free survival, and complications in patients with colorectal cancer liver metastases.
Okan Akhan   +11 more
core   +1 more source

Liver transplantation for colorectal cancer with liver metastases

open access: yesThe Oncologist
Abstract Over the last decade, multiple clinical trials have demonstrated a survival benefit for liver transplantation in colorectal cancer with liver metastases. Additionally, advances in donor organ preservation have expanded organ availability affording the opportunity to expand indications for liver transplantation, such as ...
Benjamin E Ueberroth   +3 more
openaire   +2 more sources

Use of cytoceratin-20 in revealing of colorectal cancer metastases in liver [PDF]

open access: yesСаратовский научно-медицинский журнал, 2013
The aim of the study is to evaluate the possibilities of immunohistochemical revealing of colorectal cancer micro-metastases in liver and to determine their prognostic significance. Material et metods.
Fedorina Т.A.   +2 more
doaj  

De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity

open access: yesGenome Medicine, 2021
Background Gene expression-based subtyping has the potential to form a new paradigm for stratified treatment of colorectal cancer. However, current frameworks are based on the transcriptomic profiles of primary tumors, and metastatic heterogeneity is a ...
Seyed H. Moosavi   +11 more
doaj   +1 more source

How to Best Image Colorectal Liver Metastases

open access: yes, 2020
Purpose of Review Colorectal liver metastases affect about half of the patients with colorectal cancer and have an impact on prognosis. Resection of liver metastases, even after downstaging with chemotherapy, improves patient survival.
Zamboni, G. A.   +2 more
core   +1 more source

Mouse Models of Colorectal Cancer and Liver Metastases [PDF]

open access: yesDigestive Surgery, 2005
Colorectal cancer (CRC) is one of the most common malignancies in the western world. Its high mortality rates are particularly related to the occurrence of liver metastases. Many mouse models have been developed to evaluate the various features of CRC in human.
M W, Heijstek   +2 more
openaire   +2 more sources

Treatment strategies to resectable metachronous colorectal liver metastases after adjuvant oxaliplatin‐based chemotherapy for primary colorectal cancer

open access: yes, 2022
International audienceOutcome of patients who develop resectable metachronous colorectal liver metastases (CLM) after adjuvant oxaliplatin‐based chemotherapy for Stage III colorectal cancer (CRC) is not well defined and the value of preoperative ...
Pessaux, Patrick   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy